160 related articles for article (PubMed ID: 22309801)
1. The relationship between polycystic ovary syndrome, glucose tolerance status and serum preptin level.
Bu Z; Kuok K; Meng J; Wang R; Xu B; Zhang H
Reprod Biol Endocrinol; 2012 Feb; 10():10. PubMed ID: 22309801
[TBL] [Abstract][Full Text] [Related]
2. Circulating preptin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.
Yang G; Li L; Chen W; Liu H; Boden G; Li K
Ann Med; 2009; 41(1):52-6. PubMed ID: 18618352
[TBL] [Abstract][Full Text] [Related]
3. Preptin in women with polycystic ovary syndrome.
Mierzwicka A; Kuliczkowska-Plaksej J; Kolačkov K; Bolanowski M
Gynecol Endocrinol; 2018 Jun; 34(6):470-475. PubMed ID: 29374985
[TBL] [Abstract][Full Text] [Related]
4. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
5. Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patients.
Şentürk Ş; Hatirnaz S; Kanat-Pektaş M
Med Sci Monit; 2018 Oct; 24():7517-7523. PubMed ID: 30343311
[TBL] [Abstract][Full Text] [Related]
6. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
[TBL] [Abstract][Full Text] [Related]
7. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ersoy R; Karakoç A; Yetkin I; Ayvaz G; Cakir N; Arslan M
Hum Reprod; 2005 Sep; 20(9):2414-20. PubMed ID: 15890734
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann DA; Barnes RB; Rosenfield RL; Cavaghan MK; Imperial J
Diabetes Care; 1999 Jan; 22(1):141-6. PubMed ID: 10333916
[TBL] [Abstract][Full Text] [Related]
9. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.
Ehrmann DA; Kasza K; Azziz R; Legro RS; Ghazzi MN;
J Clin Endocrinol Metab; 2005 Jan; 90(1):66-71. PubMed ID: 15507516
[TBL] [Abstract][Full Text] [Related]
10. Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome.
Song do K; Lee H; Sung YA; Oh JY
Yonsei Med J; 2016 Nov; 57(6):1404-11. PubMed ID: 27593868
[TBL] [Abstract][Full Text] [Related]
11. Elevated circulating levels of YKL-40 are a marker of abnormal glucose tolerance in women with polycystic ovary syndrome.
Celik C; Abali R; Guzel S; Bastu E; Kucukyalcin V; Yilmaz M
Clin Endocrinol (Oxf); 2012 Dec; 77(6):893-7. PubMed ID: 22583189
[TBL] [Abstract][Full Text] [Related]
12. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
Celik C; Tasdemir N; Abali R; Bastu E; Yilmaz M
Fertil Steril; 2014 Apr; 101(4):1123-8.e1. PubMed ID: 24502891
[TBL] [Abstract][Full Text] [Related]
13. The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome.
Lee H; Oh JY; Sung YA; Chung H; Cho WY
Endocrine; 2009 Oct; 36(2):326-32. PubMed ID: 19688613
[TBL] [Abstract][Full Text] [Related]
14. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
[TBL] [Abstract][Full Text] [Related]
15. Using simple clinical measures to predict insulin resistance or hyperglycemia in girls with polycystic ovarian syndrome.
Cree-Green M; Cai N; Thurston JE; Coe GV; Newnes L; Garcia-Reyes Y; Baumgartner AD; Pyle L; Nadeau KJ
Pediatr Diabetes; 2018 Dec; 19(8):1370-1378. PubMed ID: 30246333
[TBL] [Abstract][Full Text] [Related]
16. Assessment of insulin resistance in Chinese PCOS patients with normal glucose tolerance.
Gao J; Zhou L; Hong J; Chen C
Gynecol Endocrinol; 2017 Nov; 33(11):888-891. PubMed ID: 28675705
[TBL] [Abstract][Full Text] [Related]
17. Intercellular adhesion molecule-1 expression and serum levels as markers of pre-clinical atherosclerosis in polycystic ovary syndrome.
Rashad NM; El-Shal AS; Abomandour HG; Aboelfath AMK; Rafeek MES; Badr MS; Ali AE; Yousef MS; Fathy MA; Sharaf El Din MTA
J Ovarian Res; 2019 Oct; 12(1):97. PubMed ID: 31629408
[TBL] [Abstract][Full Text] [Related]
18. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
19. [Effect of acupuncture on vascular endothelial function in patients of polycystic ovary syndrome with different glucose tolerance status].
Zhang JX; You XM; Yang J; Liu Y; Huang S; Lin QP; Xu JB
Zhongguo Zhen Jiu; 2021 Feb; 41(2):155-60. PubMed ID: 33788462
[TBL] [Abstract][Full Text] [Related]
20. DPP4 INHIBITOR SITAGLIPTIN AS A POTENTIAL TREATMENT OPTION IN METFORMIN-INTOLERANT OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PILOT RANDOMIZED STUDY.
Ferjan S; Janez A; Jensterle M
Endocr Pract; 2018 Jan; 24(1):69-77. PubMed ID: 29144805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
